Avita Corporation 4735

Avita Medical (NASDAQ:RCEL) expects continued sequential revenue growth and aims to reach cash flow breakeven in the fourth quarter of 2025, President and CEO Cary Vance said at the Canaccord 46th Annual Boston Growth Conference. Vance, who has been CEO for about 10 months after previously serving

Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 18% from a year earlier and 13% sequentially, as growth in its RECELL wound-care product and newer portfolio offerings supported results. President and Chief Executive Officer Cary Vance said the company’s U.S. RE

Avita Medical (NASDAQ:RCEL) executives told investors they are focused on making the business more predictable and execution-driven in 2026, following what they described as a headwind-heavy 2025 that included reimbursement disruption, a sales force reconfiguration, and repeated amendments tied to r

Hong Kong's Hang Seng University has acquired office units in a commercial building in the New Territories for HK$90 million (US$11.6 million), making it the latest school to purchase real estate amid a government push to turn the city into a global education hub. The acquisition covers 16 office units measuring 19,139 sq ft on the 11th floor of Metropole Square in Sha Tin, together with four car parking spaces. The seller was listed company Alco Holdings, which manufactures and sells consumer e